Cromos Pharma Launches an Ulcerative Colitis Clinical Trial in Türkiye
Cromos Pharma has launched a late phase clinical trial on Ulcerative Colitis in Türkiye, aiming to explore innovative treatments for this challenging condition. The company successfully engaged with key opinion leaders in the field, ensuring comprehensive expertise is applied to the study. This represents an important step for Cromos Pharma as it expands its presence into Türkiye, opening doors for future endeavors.
2023